The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl 6-methyl-4-(3-nitrophenyl)-2-oxo-3-[2-(5-{phenylamino}-1,3,4-thiadiazol-2-yl)ethyl]-1,2,3,4-tetrahydropyrimidine-5-carboxylate ID: ALA4069634
PubChem CID: 137639831
Max Phase: Preclinical
Molecular Formula: C24H24N6O5S
Molecular Weight: 508.56
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C1=C(C)NC(=O)N(CCc2nnc(Nc3ccccc3)s2)C1c1cccc([N+](=O)[O-])c1
Standard InChI: InChI=1S/C24H24N6O5S/c1-3-35-22(31)20-15(2)25-24(32)29(21(20)16-8-7-11-18(14-16)30(33)34)13-12-19-27-28-23(36-19)26-17-9-5-4-6-10-17/h4-11,14,21H,3,12-13H2,1-2H3,(H,25,32)(H,26,28)
Standard InChI Key: JCPUIMRWUPQSRO-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
9.9627 -8.7191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9632 -7.9019 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2545 -7.4928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5492 -7.9009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5486 -8.7181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2533 -9.1272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8404 -7.4918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1351 -7.8999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8410 -6.6746 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6726 -7.4938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3773 -7.9029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1713 -6.6804 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.0867 -7.4948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8337 -7.8256 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3820 -7.2196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9739 -6.5102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3047 -5.7673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1152 -5.6797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5990 -6.3433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4095 -6.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7444 -5.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2647 -4.8492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4501 -4.9326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6715 -9.1282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2550 -6.6756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9644 -6.2675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9650 -5.4503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2562 -5.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5510 -5.4493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5504 -6.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6744 -5.0423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6750 -4.2251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3791 -5.4514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8392 -9.1262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1322 -6.2655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1328 -5.4483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 2 0
7 9 1 0
4 7 1 0
10 11 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
12 16 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
18 23 2 0
17 18 1 0
16 17 1 0
11 13 1 0
2 10 1 0
1 24 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
31 32 2 0
31 33 1 0
27 31 1 0
3 25 1 0
5 34 1 0
35 36 1 0
9 35 1 0
M CHG 2 31 1 33 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.56Molecular Weight (Monoisotopic): 508.1529AlogP: 4.34#Rotatable Bonds: 9Polar Surface Area: 139.59Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.01CX Basic pKa: ┄CX LogP: 3.34CX LogD: 3.34Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.25Np Likeness Score: -1.82
References 1. Teleb M, Zhang FX, Huang J, Gadotti VM, Farghaly AM, AboulWafa OM, Zamponi GW, Fahmy H.. (2017) Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain., 25 (6): [PMID:28233679 ] [10.1016/j.bmc.2017.02.015 ]